After recently expanding operations into new countries including Oman, Lebanon, Venezuela, Bolivia and Kosovo, Beximco Pharmaceuticals announced growth of 7.5% in export sales to BDT697.2m ($8.22m) for its financial third quarter ended 31 March 2021. The company’s export sales grew by 2.4% to BDT2.09bn for the full first nine months of its financial year.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?